Kezar Life Sciences Inc (DE:2KZ0)
FRANKFURT:2KZ0
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 7.00M | $ 0.00 | $ 0.00 |
| Gross Profit | $ -897.00K | $ -1.04M | $ 7.00M | $ 0.00 | $ -1.51M |
| Operating Income | $ -52.27M | $ -90.61M | $ -111.42M | $ -71.16M | $ -54.66M |
| EBITDA | $ -51.37M | $ -81.10M | $ -99.25M | $ -66.03M | $ -52.96M |
| Net Income | $ -56.03M | $ -83.74M | $ -101.87M | $ -68.24M | $ -54.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 71.88M | $ 132.25M | $ 201.37M | $ 276.56M | $ 208.35M |
| Total Assets | $ 76.65M | $ 144.68M | $ 221.24M | $ 299.57M | $ 217.93M |
| Total Debt | $ 2.33M | $ 16.18M | $ 18.93M | $ 21.26M | $ 14.04M |
| Net Debt | $ -69.55M | $ -25.57M | $ -16.56M | $ -19.19M | $ -48.84M |
| Total Liabilities | $ 6.57M | $ 27.77M | $ 33.66M | $ 29.70M | $ 21.06M |
| Stockholders' Equity | $ 70.07M | $ 116.92M | $ 187.57M | $ 269.87M | $ 196.88M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.78M | $ -74.24M | $ -83.45M | $ -60.42M | $ -42.75M |
| Operating Cash Flow | $ -51.78M | $ -74.21M | $ -81.64M | $ -58.85M | $ -42.44M |
| Investing Cash Flow | $ 92.46M | $ 80.43M | $ 76.05M | $ -91.39M | $ -28.44M |
| Financing Cash Flow | $ -10.59M | $ 103.00K | $ 638.00K | $ 127.86M | $ 112.58M |